How much funding has LeaFix Medical raised?

LeaFix Medical has raised $5.0M in total funding, most recently a Series A round.

Who are LeaFix Medical's investors?

LeaFix Medical's investors include Pitango Growth, Innovation Authority.

Where is LeaFix Medical headquartered?

LeaFix Medical is headquartered in Givat Brener, Israel.

What industry is LeaFix Medical in?

LeaFix Medical operates in Healthcare, Medical Devices.

LeaFix Medical

Minimally invasive mitral valve repair

Givat Brener, Israel · $5.0M raised

Healthcare

Medical Devices

Headquarters: Givat Brener
Business Model: B2B
Website: leafix-medical.com

Total Funding: $5.0M
Last Round: $5.0M Series AJul 2025
Rounds: 1

About

LeaFix Medical specializes in developing a transcatheter solution for functional mitral valve regurgitation repair, focusing on augmentation of the anterior leaflet. The system comprises an implant and a delivery mechanism designed to expand the implant within the leaflet, enlarging the leaflet area and facilitating coaptation. The company targets patients with secondary mitral regurgitation, a condition often linked to left ventricular disease, and aims to provide a minimally invasive alternative to traditional surgical methods. LeaFix is currently in the animal trial phase, showing promising results. Co-founded by Dr. Boris Orlov, a cardiac surgeon, and Boaz Harari, an engineer with two decades of experience.

Summary

LeaFix Medical is a Healthcare company based in Givat Brener, Israel. It has raised $5.0M in total across 1 round, most recently a $5.0M Series A round in Jul 2025. Investors include Pitango Growth and Innovation Authority.